Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Surgery Partners CS (NQ: SGRY )

27.92 -1.13 (-3.89%)
Streaming Delayed Price Updated: 1:13 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 640,892
Open 28.98
Bid (Size) 27.89 (4)
Ask (Size) 27.91 (3)
Prev. Close 29.05
Today's Range 27.36 - 29.20
52wk Range 22.05 - 40.31
Shares Outstanding 82,478,580
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
Top mid-cap stock performers: VIRT (+30%), VFC (+22%), NFE (+20%), RIOT (+16%), CLVT (+14%), AMN (+14%), BKU (+13%), MARA (+12%), EXPI (+12%), ZETA (+11%), NATL (+11%). 
Via Benzinga
Critical Insights From Surgery Partners Analyst Ratings: What You Need To Know
Via Benzinga

Performance

YTD
-11.73%
-11.73%
1 Month
+14.01%
+14.01%
3 Month
+16.14%
+16.14%
6 Month
-13.37%
-13.37%
1 Year
-28.96%
-28.96%

More News

Read More
SGRY Stock Earnings: Surgery Partners Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Expert Ratings For Surgery Partners
Via Benzinga
Preview: Surgery Partners's Earnings
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
The Latest Analyst Ratings for Surgery Partners
Via Benzinga
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For February 26, 2024
Via Benzinga
Expert Ratings for Surgery Partners
Via Benzinga
Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock
Via Benzinga
Surgery Partners feeling no pinch from macroeconomic weakness
Via MarketBeat
Exposures COVID-19
Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
A Preview Of Surgery Partners's Earnings
Via Benzinga
Analyst Expectations for Surgery Partners's Future
Via Benzinga
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors
From Teladoc Health, Inc.
Via GlobeNewswire
Earnings Scheduled For November 7, 2023
Via Benzinga
Surgery Partners Stock Getting Closer To Key Technical Benchmark
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Via MarketBeat
Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.